Welcome to the Centre for Healthy Brain Ageing (CHeBA)
Our work covers the entire spectrum of neuroscience research, including clinical research, epidemiology, social determinants of health, neuroimaging, genetics, multiomics, and cell biology. The centrepiece of our work relates to our well-established ageing cohort studies and our international consortia. CHeBA has strong links with teaching hospitals, aged care providers, and state and federal governments to translate our research into better treatments, care and health policy for older people.
Our mission is to conduct innovative research and provide the empirical basis to prevent and treat dementia and achieve healthy brain ageing for all Australians.
Explore
About us
We're a premier research institution at UNSW Sydney, investigating brain ageing. CHeBA was established in October 2012 and is headed by internationally acclaimed leaders in the field, Professor Henry Brodaty and Professor Perminder Sachdev.
Clinical & care
CHeBA’s vision is to achieve, through research, healthier brain ageing and better clinical care of age-related brain diseases.
Study with us
The Centre for Healthy Brain Ageing (CHeBA) conducts multidisciplinary research into issues associated with brain ageing. CHeBA welcomes all research students at undergraduate and postgraduate levels.
Events
Explore CHeBA’s upcoming and past events focused on brain health, dementia research, and healthy ageing—featuring expert lectures, community forums, and awareness initiatives.
Latest from the Blog: The Brain Dialogues
Important Notice Regarding False Endorsements
It has come to our attention that Professor Henry Brodaty’s name and image are being misused in online advertisements - reportedly on platforms like Facebook - to promote various drugs, supplements, or herbal remedies claiming to improve brain health or prevent dementia.
We want to make it absolutely clear that neither Professor Henry Brodaty nor UNSW have endorsed any commercial products for brain health or dementia prevention. These claims are false and misleading.
Professor Brodaty’s research and public advocacy focus on evidence-based, non-pharmacological strategies for maintaining cognitive health, including:
- A healthy Mediterranean-style diet
- Regular physical and mental activity
- Social engagement and emotional well-being
Professor Henry Brodaty has commented on drugs approved by the Therapeutic Goods Administration - TGA such as donanemab and lecanemab or others in development in which case he declares any conflicts of interest such as serving on a company’s advisory board.
We urge the public to be cautious of advertisements that appear to misuse the names of researchers or clinicians to promote unverified products. If you see such content, please report it to the platform and avoid sharing it further.
For accurate information on dementia prevention, we encourage you to consult reputable sources such as the Centre for Healthy Brain Ageing (CHeBA) or Dementia Australia.